Stay updated on Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.

Latest updates to the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page
- Check2 days agoChange DetectedType 2 diabetes was added to the study keywords/MeSH terms, and a related topics entry for MedlinePlus Genetics was introduced. These additions improve discoverability and provide consumer health context without altering the main study content.SummaryDifference0.2%

- Check9 days agoChange DetectedRevision updated to v3.5.4. The 'Type 2 diabetes' condition and the 'MedlinePlus Genetics' related topics were removed from the study record.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s footer and related-topic area were updated, including the listed “Type 2 diabetes” related resources and a change to the site revision version. No study-level information (design, outcomes, eligibility, or status) appears to have been altered.SummaryDifference0.2%

- Check45 days agoChange DetectedRemoved the related topics 'Type 2 diabetes' and 'MedlinePlus Genetics' from the page's related topics section.SummaryDifference0.2%

- Check66 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check81 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.